JP2008526917A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008526917A5 JP2008526917A5 JP2007550779A JP2007550779A JP2008526917A5 JP 2008526917 A5 JP2008526917 A5 JP 2008526917A5 JP 2007550779 A JP2007550779 A JP 2007550779A JP 2007550779 A JP2007550779 A JP 2007550779A JP 2008526917 A5 JP2008526917 A5 JP 2008526917A5
- Authority
- JP
- Japan
- Prior art keywords
- ion
- acid
- product according
- pharmaceutical
- ethanol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 12
- 239000000825 pharmaceutical preparation Substances 0.000 claims 8
- -1 methanesulfonate ion Chemical class 0.000 claims 6
- 239000000203 mixture Substances 0.000 claims 5
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims 3
- 239000008139 complexing agent Substances 0.000 claims 3
- 239000003814 drug Substances 0.000 claims 3
- BDAGIHXWWSANSR-UHFFFAOYSA-N formic acid Chemical compound OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims 3
- XBDQKXXYIPTUBI-UHFFFAOYSA-N propionic acid Chemical compound CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 claims 3
- 239000002904 solvent Substances 0.000 claims 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 3
- VZCYOOQTPOCHFL-OWOJBTEDSA-N (E)-but-2-enedioate;hydron Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 claims 2
- 229960000686 Benzalkonium Chloride Drugs 0.000 claims 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N HCl Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 claims 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims 2
- 239000002253 acid Substances 0.000 claims 2
- CPELXLSAUQHCOX-UHFFFAOYSA-M bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 claims 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims 2
- 150000001875 compounds Chemical class 0.000 claims 2
- GRYLNZFGIOXLOG-UHFFFAOYSA-N nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 claims 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N Benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 claims 1
- 229940093915 Gynecological Organic acids Drugs 0.000 claims 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-L L-tartrate(2-) Chemical compound [O-]C(=O)[C@H](O)[C@@H](O)C([O-])=O FEWJPZIEWOKRBE-JCYAYHJZSA-L 0.000 claims 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N Malic acid Chemical compound OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 claims 1
- FEWJPZIEWOKRBE-XIXRPRMCSA-N Mesotartaric acid Chemical compound OC(=O)[C@@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-XIXRPRMCSA-N 0.000 claims 1
- 206010038683 Respiratory disease Diseases 0.000 claims 1
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Vitamin C Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 claims 1
- 235000011054 acetic acid Nutrition 0.000 claims 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims 1
- 150000001450 anions Chemical class 0.000 claims 1
- 235000010323 ascorbic acid Nutrition 0.000 claims 1
- 239000011668 ascorbic acid Substances 0.000 claims 1
- 229960005070 ascorbic acid Drugs 0.000 claims 1
- 150000001768 cations Chemical class 0.000 claims 1
- 235000015165 citric acid Nutrition 0.000 claims 1
- 229960004106 citric acid Drugs 0.000 claims 1
- 235000019253 formic acid Nutrition 0.000 claims 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N fumaric acid Chemical compound OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 claims 1
- 239000001530 fumaric acid Substances 0.000 claims 1
- 235000011087 fumaric acid Nutrition 0.000 claims 1
- CPELXLSAUQHCOX-UHFFFAOYSA-N hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 claims 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-M iodide Chemical compound [I-] XMBWDFGMSWQBCA-UHFFFAOYSA-M 0.000 claims 1
- 239000011976 maleic acid Substances 0.000 claims 1
- 239000001630 malic acid Substances 0.000 claims 1
- 235000011090 malic acid Nutrition 0.000 claims 1
- 229940099690 malic acid Drugs 0.000 claims 1
- 150000007522 mineralic acids Chemical class 0.000 claims 1
- 229940006477 nitrate ion Drugs 0.000 claims 1
- 150000007524 organic acids Chemical class 0.000 claims 1
- 235000005985 organic acids Nutrition 0.000 claims 1
- MUBZPKHOEPUJKR-UHFFFAOYSA-L oxalate Chemical compound [O-]C(=O)C([O-])=O MUBZPKHOEPUJKR-UHFFFAOYSA-L 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 229940085991 phosphate ion Drugs 0.000 claims 1
- 238000002360 preparation method Methods 0.000 claims 1
- 235000019260 propionic acid Nutrition 0.000 claims 1
- 238000005507 spraying Methods 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 claims 1
- 239000001384 succinic acid Substances 0.000 claims 1
- 235000011044 succinic acid Nutrition 0.000 claims 1
- QAOWNCQODCNURD-UHFFFAOYSA-L sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 claims 1
- 239000011975 tartaric acid Substances 0.000 claims 1
- 235000002906 tartaric acid Nutrition 0.000 claims 1
- 229960001367 tartaric acid Drugs 0.000 claims 1
- JJBCOBRXLMNTOK-UHFFFAOYSA-N CC1(C(OC(C2)CC3[N+](C)(C)C2C2OC32)=O)c2ccccc2-c2c1cccc2 Chemical compound CC1(C(OC(C2)CC3[N+](C)(C)C2C2OC32)=O)c2ccccc2-c2c1cccc2 JJBCOBRXLMNTOK-UHFFFAOYSA-N 0.000 description 1
Claims (14)
- 式中、X-が塩素イオン、臭素イオン、4-トルエンスルホン酸イオン及びメタンスルホン酸イオンの中から選択される、少なくとも1種の式1の化合物を含有する、請求項1記載の医薬品。
- エタノール及び水の混合物を溶媒として含有し、これらの混合物におけるエタノールの質量%が5〜99%の範囲である、請求項1又は2記載の医薬品。
- エタノール及び水の混合物を溶媒として含有し、これらの混合物におけるエタノールの質量%が10〜96%の範囲である、請求項1〜3のいずれか1項に記載の医薬品。
- 薬理学的に許容される酸が、無機酸である塩酸、臭化水素酸、硝酸、硫酸及びリン酸の中から選択されるか、又は有機酸であるアスコルビン酸、クエン酸、リンゴ酸、酒石酸、マレイン酸、コハク酸、フマル酸、酢酸、蟻酸及びプロピオン酸の中から選択される、請求項1〜4のいずれか1項に記載の医薬品。
- 2.5〜6.5のpHを有する、請求項1〜5のいずれか1項に記載の医薬品。
- さらなる成分として錯化剤を含有する、請求項1〜7のいずれか1項に記載の医薬品。
- 錯化剤の含有量が、100mLの溶液当たり0.1〜3mgである、請求項1〜8のいずれか1項に記載の医薬品。
- 賦形剤として塩化ベンズアルコニウムを含有する、請求項1〜9のいずれか1項に記載の医薬品。
- 塩化ベンズアルコニウムの含有量が、100mLの溶液当たり1〜50mgである、請求項10記載の医薬品。
- 呼吸器疾患の治療のための医薬組成物を調製するための、請求項1〜11のいずれか1項に記載の医薬品の使用。
- 経口又は経鼻ルートの吸入によって投薬される、請求項1〜11のいずれか1項に記載の医薬品。
- 請求項1〜11及び13のいずれか1項に記載の医薬品、及びこの医薬品を噴霧するのに適した吸入器からなる、吸入キット。
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102005001297A DE102005001297A1 (de) | 2005-01-12 | 2005-01-12 | Aerosolformulierung für die Inhalation enthaltend ein Anticholinergikum |
PCT/EP2006/050002 WO2006074970A1 (de) | 2005-01-12 | 2006-01-02 | Aerosolformulierung für die inhalation enthaltend ein anticholinergikum |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2008526917A JP2008526917A (ja) | 2008-07-24 |
JP2008526917A5 true JP2008526917A5 (ja) | 2009-02-26 |
Family
ID=36204353
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2007550779A Pending JP2008526917A (ja) | 2005-01-12 | 2006-01-02 | 抗コリン剤を含有する吸入用噴霧製剤 |
Country Status (6)
Country | Link |
---|---|
US (1) | US20060153777A1 (ja) |
EP (1) | EP1838282A1 (ja) |
JP (1) | JP2008526917A (ja) |
CA (1) | CA2593272A1 (ja) |
DE (1) | DE102005001297A1 (ja) |
WO (1) | WO2006074970A1 (ja) |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4108393A1 (de) * | 1991-03-15 | 1992-09-17 | Boehringer Ingelheim Kg | Neue ester bi- und tricyclischer aminoalkohole, ihre herstellung und ihre verwendung in arzneimitteln |
DE10203741A1 (de) * | 2002-01-31 | 2003-08-14 | Boehringer Ingelheim Pharma | Neue Fluorencarbonsäureester, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel |
US6790856B2 (en) * | 2002-01-31 | 2004-09-14 | Boehringer Ingelheim Pharma Kg | Fluorenecarboxylic acid esters, process for the manufacture thereof, and use thereof as medicaments |
ES2305479T3 (es) * | 2002-08-14 | 2008-11-01 | BOEHRINGER INGELHEIM PHARMA GMBH & CO.KG | Formulaciones aerosol para inhalacion que contienen un agente anticolinergico. |
DE102004038885A1 (de) * | 2004-08-10 | 2006-02-23 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Aerosolformulierung für die Inhalation enthaltend ein Anticholinergikum |
-
2005
- 2005-01-12 DE DE102005001297A patent/DE102005001297A1/de not_active Withdrawn
-
2006
- 2006-01-02 EP EP06700053A patent/EP1838282A1/de not_active Withdrawn
- 2006-01-02 CA CA002593272A patent/CA2593272A1/en not_active Abandoned
- 2006-01-02 JP JP2007550779A patent/JP2008526917A/ja active Pending
- 2006-01-02 WO PCT/EP2006/050002 patent/WO2006074970A1/de active Application Filing
- 2006-01-04 US US11/326,226 patent/US20060153777A1/en not_active Abandoned
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2540174A1 (en) | Aerosol formulation for inhalation, containing an anticholinergic agent | |
JP2006506345A5 (ja) | ||
AU775588B2 (en) | Novel medicament compositions, based on anticholinergically effective compounds and beta-mimetics | |
SI1940349T1 (en) | Aerosol formulation for inhalation of beta agonists | |
CN103501776A (zh) | 甘罗铵与β2激动剂的组合物 | |
AU2020202402B2 (en) | Muscarinic antagonists and combinations thereof for the treatment of airway disease in horses | |
WO2005102275B1 (en) | Galantamine salts, method of producing it and nasal composition thereof | |
JP4602767B2 (ja) | 抗コリン作用薬を含有する吸入用エアロゾル製剤 | |
JP2008509197A (ja) | 抗コリン作用薬を含む吸入用のエアロゾル製剤 | |
US20190262263A1 (en) | Compositions, devices and methods for the treatment of opioid-receptor-mediated conditions | |
JP2023510662A (ja) | 窒素酸化物を生成するための方法および組成物、ならびに気道を介して窒素酸化物を送達するためのそれらの使用 | |
JP2010509185A (ja) | 抗コリン作用薬を含む吸入用エアロゾル製剤 | |
JP2010509184A (ja) | 抗コリン作用薬を含む吸入用エアロゾル製剤 | |
JP2010501022A5 (ja) | ||
JP2010509182A (ja) | 抗コリン作用薬を含む吸入用エアロゾル製剤 | |
CN102905689A (zh) | 包含低剂量纳曲酮的液体鼻喷雾 | |
EP2978407B1 (en) | Aqueous solution composition containing ipratropium and oxymetazoline | |
JP2005531528A5 (ja) | ||
KR20140049001A (ko) | 조성물 | |
WO2012110462A1 (en) | Liquid propellant-free formulation comprising an antimuscarinic drug | |
AU2013360692A1 (en) | Pharmaceutical formulation comprising ciclesonide | |
JP2008526917A5 (ja) | ||
JP2000169378A (ja) | 咽頭疾患用組成物 | |
CN1267097C (zh) | 噻唑类衍生物在制备可用于治疗慢性阻塞性肺病的药物中的用途 | |
TWI352593B (en) | A medicament for treating chronic obstructive pulm |